You are here
Amgen's new cholesterol drug falls short as sales driver
AMGEN Inc's new cholesterol drug is still struggling to gain traction, missing analysts' estimates at a time when the biotechnology giant is anxious for its newer drugs to make up for slowing sales of its older ones.
Sales of the drug, called Repatha, for the first
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org